Further steps towards artificial eggs and sperm
By New Scientist,
New Scientist
| 06. 20. 2005
Human embryonic stem cells have been coaxed in the lab to develop into the early forms of cells which eventually become eggs or sperm, UK researchers have revealed.
Work by several groups has shown that a tiny proportion of human embryonic stem cells (ESCs) spontaneously develop into primordial germ cells when allowed to differentiate in a dish. In this latest study, Behrouz Aflatoonian and colleagues at the University of Sheffield, produced primordial germ cells which began to express the proteins characteristic of sperm cells, while others resembled eggs.
But there is still a long way to go before doctors can even think of trying the technique in people. The researchers have not proved, for example, that the cells that express sperm proteins have divided properly and possess only one set of chromosomes like normal sperm.
The team presented their results at a meeting of the European Society for Human Reproduction and Embryology (ESHRE) in Copenhagen, Denmark, on Monday.
Ultimate aims
The dream of growing sperm and egg cells outside the body remains exactly that for the moment. Although progress has...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...